Andtbacka Discusses Long-Term Data and Next Steps With T-VEC in Melanoma

Talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma, according to long-term follow-up results from the pivotal phase III OPTiM study.

New international research project identifies subtypes of ocular melanoma

A new international research project, involving the University of Liverpool’s leading eye cancer research group, has identified specific subtypes of ocular melanoma that will help develop improved management strategies and therapies in the future.

Endometriosis Linked to Higher Risk of Melanoma, but Not Other Skin Cancers, Study Suggests

Women with a history of endometriosis may have an increased risk of developing melanoma, but no association was seen in other skin cancers, according to the results of a large prospective analysis.

Long-Term T-VEC Results in Melanoma Provide Reassurance for Clinicians and Patients, Expert Says

According to long-term follow-up results from the pivotal phase III OPTiM study, talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma.

Cancer in the News

Feature Articles

Annual cost of melanoma increases seven-fold to $200 million

Australians are being slow to heed advice to slip, slop, slap, with the annual cost of treating melanoma ballooning nearly seven-fold to $200 million over the past 16 years.

Read the full story

Posted in Melanoma In The News, Information, Patient Information

Computed tomography useful for staging head, neck melanoma

(HealthDay)—Patients with head and neck melanoma benefit from the introduction of initial staging using computed tomography (CT), according to research published online Aug. 21 in Head & Neck.

Read the full story

Posted in Melanoma In The News, Information

“I’m still inspired”: Tributes for Clare Oliver 10 years on

Neil Mitchell and Dr Grant McArthur have paid tribute to anti-solarium campaigner Clare Oliver, 10 years on from her untimely death.

Read the full story

Posted in Melanoma In The News, Information, Patient Stories

Dr. Daud Discusses the Current Status of Immunotherapy in Melanoma

Adil Daud, MD, clinical professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, at University of California, San Francisco, discusses the current status of immunotherapy in melanoma.

Read the full story

Posted in Melanoma In The News, OncLive Videos

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories